A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up
-
Published:2014-11-14
Issue:
Volume:4
Page:
-
ISSN:2234-943X
-
Container-title:Frontiers in Oncology
-
language:
-
Short-container-title:Front. Oncol.
Author:
Mantz Constantine
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献